SORAVE-Sorafenib and Everolimus in Solid Tumors. A Phase I Clinical Trial to Evaluate the Safety of Combined Sorafenib and Everolimus Treatment in Patients With Relapsed Solid Tumors.
Phase of Trial: Phase I
Latest Information Update: 03 Jun 2016
At a glance
- Drugs Everolimus (Primary) ; Sorafenib
- Indications Solid tumours
- Focus Therapeutic Use
- Acronyms SORAVE
- 10 Jun 2017 Biomarkers information updated
- 24 May 2016 Status changed from recruiting to completed.
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.